科研项目详细信息
SBIR Phase II: Targeted Nanoparticle Delivery Agent for Treatment of Adult Leukemia
Jon Nagy
NanoValent Pharmaceuticals, Inc.
Subject:工程和技术(综合)
美国|英语
01至01
Source: National Science Foundation